Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine Dehydrogenase

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|14|2028-2034

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.14, 2017-05, pp. : 2028-2034

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implementation of pharmacogenetics in clinical practice is challenging

By van Schie Rianne MF   de Boer Anthonius   Maitland-van der Zee Anke Hilse  

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1231-1233

Future Medicine

Access to resources Recommend Favorite

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics

By Mattison Lori K   Soong Richie   Diasio Robert B  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 485-492

Future Medicine

Access to resources Recommend Favorite

Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy

By Zhang Xue   Diasio Robert B  

Pharmacogenomics, Vol. 8, Iss. 3, 2007-03 ,pp. : 257-265

Future Medicine

Access to resources Recommend Favorite

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

By  

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics and the Future of Clinical Pharmacy Practice

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 1, 2008-03 ,pp. : 7-8

John Wiley & Sons Inc

Access to resources Recommend Favorite